These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 9797827

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Protective efficacy of a Plasmodium vivax circumsporozoite protein-based vaccine in Aotus nancymaae is associated with antibodies to the repeat region.
    Yadava A, Hall CE, Sullivan JS, Nace D, Williams T, Collins WE, Ockenhouse CF, Barnwell JW.
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3268. PubMed ID: 25329054
    [Abstract] [Full Text] [Related]

  • 24. Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum.
    Calvo-Calle JM, de Oliveira GA, Clavijo P, Maracic M, Tam JP, Lu YA, Nardin EH, Nussenzweig RS, Cochrane AH.
    J Immunol; 1993 Feb 15; 150(4):1403-12. PubMed ID: 7679427
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Plasmodium vivax: a monoclonal antibody recognizes a circumsporozoite protein precursor on the sporozoite surface.
    Gonzalez-Ceron L, Rodriguez MH, Wirtz RA, Sina BJ, Palomeque OL, Nettel JA, Tsutsumi V.
    Exp Parasitol; 1998 Nov 15; 90(3):203-11. PubMed ID: 9806864
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran.
    Mehrizi AA, Zakeri S, Salmanian AH, Sanati MH, Djadid ND.
    Acta Trop; 2009 Oct 15; 112(1):1-7. PubMed ID: 19481997
    [Abstract] [Full Text] [Related]

  • 30. Biological, immunological and functional properties of two novel multi-variant chimeric recombinant proteins of CSP antigens for vaccine development against Plasmodium vivax infection.
    Shabani SH, Zakeri S, Salmanian AH, Amani J, Mehrizi AA, Snounou G, Nosten F, Andolina C, Mourtazavi Y, Djadid ND.
    Mol Immunol; 2017 Oct 15; 90():158-171. PubMed ID: 28800475
    [Abstract] [Full Text] [Related]

  • 31. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.
    Yang C, Collins WE, Xiao L, Saekhou AM, Reed RC, Nelson CO, Hunter RL, Jue DL, Fang S, Wohlhueter RM, Udhayakumar V, Lal AA.
    Vaccine; 1997 Mar 15; 15(4):377-86. PubMed ID: 9141208
    [Abstract] [Full Text] [Related]

  • 32. Antigenic analysis of the repeat domain of the circumsporozoite protein of Plasmodium vivax.
    Romero P, Heimer EP, Herrera S, Felix AM, Nussenzweig RS, Zavala F.
    J Immunol; 1987 Sep 01; 139(5):1679-82. PubMed ID: 2442254
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques.
    Vanloubbeeck Y, Pichyangkul S, Bayat B, Yongvanitchit K, Bennett JW, Sattabongkot J, Schaecher K, Ockenhouse CF, Cohen J, Yadava A, P. vivax vaccine study group.
    Vaccine; 2013 Dec 16; 31(52):6216-24. PubMed ID: 24144477
    [Abstract] [Full Text] [Related]

  • 34. Recognition of synthetic 104-mer and 102-mer peptides corresponding to N- and C-terminal nonrepeat regions of the Plasmodium falciparum circumsporozoite protein by sera from human donors.
    Lopez JA, Roggero MA, Duombo O, Gonzalez JM, Tolle R, Koita O, Arevalo-Herrera M, Herrera S, Corradin G.
    Am J Trop Med Hyg; 1996 Oct 16; 55(4):424-9. PubMed ID: 8916800
    [Abstract] [Full Text] [Related]

  • 35. Widespread occurrence of antibodies against circumsporozoite protein and against blood forms of Plasmodium vivax, P. falciparum and P. malariae in Brazilian wild monkeys.
    Duarte AM, Porto MA, Curado I, Malafronte RS, Hoffmann EH, de Oliveira SG, da Silva AM, Kloetzel JK, Gomes Ade C.
    J Med Primatol; 2006 Apr 16; 35(2):87-96. PubMed ID: 16556295
    [Abstract] [Full Text] [Related]

  • 36. Plasmodium vivax thrombospondin related adhesion protein: immunogenicity and protective efficacy in rodents and Aotus monkeys.
    Castellanos A, Arévalo-Herrera M, Restrepo N, Gulloso L, Corradin G, Herrera S.
    Mem Inst Oswaldo Cruz; 2007 Jun 16; 102(3):411-6. PubMed ID: 17568948
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Identification of HLA-A2 restricted CD8(+) T-lymphocyte responses to Plasmodium vivax circumsporozoite protein in individuals naturally exposed to malaria.
    Arévalo-Herrera M, Valencia AZ, Vergara J, Bonelo A, Fleischhauer K, González JM, Restrepo JC, López JA, Valmori D, Corradin G, Herrera S.
    Parasite Immunol; 2002 Mar 16; 24(3):161-9. PubMed ID: 12078650
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Development of a polymorphic strain of Plasmodium vivax in monkeys.
    Collins WE, Sattabongkot J, Wirtz RA, Skinner JC, Broderson JR, Millet PG, Morris CL, Richardson BB, Sullivan J, Filipski VK.
    J Parasitol; 1992 Jun 16; 78(3):485-91. PubMed ID: 1597793
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.